These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27765765)

  • 1. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
    Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
    Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
    Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk.
    Yin W; Li F; Tan X; Wang H; Jiang W; Wang X; Li S; Zhang Y; Han Q; Wang Y; Du J
    Am J Hypertens; 2021 Nov; 34(11):1209-1216. PubMed ID: 34232291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
    Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
    Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).
    Wang DD; Toledo E; Hruby A; Rosner BA; Willett WC; Sun Q; Razquin C; Zheng Y; Ruiz-Canela M; Guasch-Ferré M; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Ros E; Lapetra J; Fito M; Aros F; Serra-Majem L; Lee CH; Clish CB; Liang L; Salas-Salvadó J; Martínez-González MA; Hu FB
    Circulation; 2017 May; 135(21):2028-2040. PubMed ID: 28280233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus.
    Hilvo M; Jylhä A; Lääperi M; Jousilahti P; Laaksonen R
    Eur Heart J Open; 2021 Nov; 1(3):oeab010. PubMed ID: 35919880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy.
    Timmerman N; Waissi F; Dekker M; de Borst GJ; van Bennekom J; de Winter RJ; Hilvo M; Jylhä A; Pasterkamp G; de Kleijn DPV; Laaksonen R
    Sci Rep; 2022 Apr; 12(1):5521. PubMed ID: 35365690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
    Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
    Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies.
    Mantovani A; Dugo C
    J Clin Lipidol; 2020; 14(2):176-185. PubMed ID: 32067904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Ceramides.
    Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.
    Wretlind A; Curovic VR; Suvitaival T; Theilade S; Tofte N; Winther SA; Vilsbøll T; Vestergaard H; Rossing P; Legido-Quigley C
    Diabetes; 2023 Oct; 72(10):1493-1501. PubMed ID: 37478203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.
    Churchill RA; Gochanour BR; Scott CG; Vasile VC; Rodeheffer RJ; Meeusen JW; Jaffe AS
    Biomarkers; 2024 Jun; 29(4):161-170. PubMed ID: 38666319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.
    Aalto K; Havulinna AS; Jalkanen S; Salomaa V; Salmi M
    Circ Cardiovasc Genet; 2014 Aug; 7(4):529-35. PubMed ID: 24850810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
    Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
    ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients.
    Michelucci E; Rocchiccioli S; Gaggini M; Ndreu R; Berti S; Vassalle C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.